Clinical Trial Update: QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2 trial of AMG 479 with paclitaxel and carboplatin as first-line therapy for advanced squamous non-small cell lung cancer. The study was terminated and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• AMG 479
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: NantCell, Inc. | Conditions: Advanced Squamous Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-09-25